VICTORY CAPITAL MANAGEMENT INC - LINEAGE CELL THERAPEUTICS IN ownership

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 91 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of LINEAGE CELL THERAPEUTICS IN
ValueSharesWeighting
Q2 2024$24,214
-33.7%
24,280
-1.6%
0.00%
Q1 2024$36,512
+42.6%
24,670
+5.0%
0.00%
Q4 2023$25,610
+12.9%
23,495
+22.2%
0.00%
Q3 2023$22,691
-12.7%
19,230
+4.4%
0.00%
Q2 2023$25,981
-8.1%
18,426
-2.3%
0.00%
Q1 2023$28,281
+26.7%
18,854
-1.1%
0.00%
Q4 2022$22,315
+1.4%
19,073
-0.0%
0.00%
Q3 2022$22,000
-38.9%
19,080
-15.8%
0.00%
Q2 2022$36,000
+33.3%
22,651
+1.1%
0.00%
Q1 2022$27,000
-53.4%
22,410
-4.8%
0.00%
Q4 2021$58,000
-4.9%
23,539
-2.4%
0.00%
Q3 2021$61,000
-12.9%
24,113
-1.7%
0.00%
Q2 2021$70,000
+27.3%
24,527
+4.8%
0.00%
Q1 2021$55,000
+31.0%
23,394
-3.0%
0.00%
Q4 2020$42,000
+100.0%
24,122
+5.4%
0.00%
Q3 2020$21,0000.0%22,889
-5.4%
0.00%
Q2 2020$21,000
-50.0%
24,183
-51.5%
0.00%
Q1 2020$42,000
+68.0%
49,820
+92.6%
0.00%
Q3 2019$25,00025,8670.00%
Other shareholders
LINEAGE CELL THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 34,935,485$52,403,2283.69%
Raffles Associates 1,536,946$2,305,4193.14%
Defender Capital, LLC. 5,136,085$7,704,1282.69%
Prescott General Partners LLC 1,851,851$2,777,7770.22%
DAFNA Capital Management LLC 140,000$210,0000.06%
Beirne Wealth Consulting Services, LLC 45,000$67,5000.05%
CTC Capital Management, LLC 14,100$21,1500.04%
Diametric Capital, LP 50,875$76,3130.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 781,766$1,172,6490.03%
One68 Global Capital, LLC 13,377$20,0660.03%
View complete list of LINEAGE CELL THERAPEUTICS IN shareholders